Transparency Market Research published new market report" Transcriptomics Technologies Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 ".The global transcriptomics technologies market was valued at USD 1.65 billion in 2012 and is expected to grow at a CAGR of 15.9% from 2013 to 2019, to reach an estimated value of USD 4.6 billion in 2019.Transcriptomics refer to the structural and functional aspects of complete set of transcripts present in an individual or group of cells. The demand for transcriptomics research is increasing majorly due to consistent technological upgradations in several techniques (such as polymerase chain reaction (PCR), ribonucleic acid (RNA) sequencing and microarrays, etc.) employed for transcriptome analysis. The other notable factors include increased research in the field of “omics” technologies followed by heightened preference for personalized medicine which further propel transcriptomics market growth. The major technologies employed for transcriptome analysis comprises microarrays, PCR, gene regulation studies and next generation sequencing technologies. Browse the report With Full TOC at http://www.transparencymarketresearch.com/transcriptomics-technologies-market.html

1. Transparency Market Research
Transcriptomics
Technologies Market Global Industry Analysis,
Size, Share, Growth,
Trends and Forecast, 2013
- 2019
Single User License: US $ 4795
Buy Now
Request Sample
Published Date: Oct 2013
97 Pages Report
Multi User License: US $ 7795
Corporate User License: US $ 10795
REPORT DESCRIPTION
Transcriptomics Technologies Market is Expected to Reach USD 4.6 Billion Globally
in 2019: Transparency Market Research
Transparency Market Research is Published new Market Report “Transcriptomics
Technologies Market (Microarrays, PCR, Gene Regulation and Next Generation
Sequencing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,
2013 - 2019," The global transcriptomics technologies market was valued at USD 1.65
billion in 2012 and is expected to grow at a CAGR of 15.9% from 2013 to 2019, to reach an
estimated value of USD 4.6 billion in 2019.
Transcriptome refers to the complete set of all coding and non-coding ribonucleic acid (RNA)
molecules present in an individual or population of cells. Transcriptome accounts for about
less than 5% of the total genome. Transcriptomics research refers to the study of functional
and structural aspects of RNA transcripts in a given cell. This research provides insights
about the gene expression and gene regulation mechanisms in normal and diseased cells
such as cancerous cells. In addition it aids in identification of novel gene sequences and
potential drug targets. With the increasing preference for personalized medicine and

2. companion diagnostics, transcriptomics technologies promises increased participation of
pharmaceutical and biotechnology companies in healthcare and medical research projects.
The most important factors favoring growth of global transcriptomics market include
consistent technological upgradation followed by increased healthcare and R&D expenditure
by pharmaceutical and biotechnology companies. Also, continuous exploration of biomarkers
and novel gene sequences will drive the growth and acceptance of transcriptomics
technologies across the globe.
Lack of effective bioinformatics tools employed for transcriptome analysis is one of the
major factors expected to hamper the ready acceptance of transcriptome analysis tools and
services. In addition, lack of awareness about genomic medicine and domain expertise are
the other factors which might restrain the market growth. Increased research investments
made by several pharmaceutical and biotechnology companies to develop targeted
therapeutics, provide a growth opportunity to the transcriptomics technologies. Currently,
the trend of contract research outsourcing is advantageous for the development and
commercialization of transcriptomics research outcomes.
The global transcriptomics technologies market can be categorized by technology,
application and geography. RNA sequencing technologies have surpassed the usage of
microarrays in drug discovery and research with increased efficiency and reliability.
Transcriptomics technologies market for microarrays was the most prominent segment of
the market in 2012 by revenue. However, next generation sequencing technologies are
steadily surpassing the use of microarrays, owing to their higher efficiency, reliability and
capabilities. Extensive research activities and technological evolution of sequencing
platforms further propel adoption of next generation sequencing technologies. Another
attractive segment of this market is that of gene regulation technologies such as micro RNA
and RNA interference technology. These technologies regulate proper functioning of the
genes in normal as well as diseased cells. It is estimated that the market for gene
regulation technologies will grow at a CAGR of over 15% from 2013 to 2019.
At the regional level, North America was the largest market in 2012 for transcriptomics
technologies followed by the European region. Presence of sophisticated and well
infrastructured research and medical laboratories followed by increased participation of
respective governments in healthcare sector will propel growth and acceptance of
transcriptomics research in North American market. The Asia-Pacific region is expected to
record commendable growth by 2019 due to huge untapped potential population, rising
disposable income, increased healthcare investments and extensive research carried out in
the biotechnology field.
Transcriptomics technologies market is characterized by the presence of established players
as well as new players solely operating in this market. The major companies competing in
this market are Agilent Technologies, Inc., Affymetrix, Inc., Life Technologies Corporation,
Illumina, Inc., F-Hoffmann La Roche Ltd. and Thermo Fisher Scientific.

3. The global transcriptomics technologies market is segmented as follows:
Transcriptomics Technologies Market, by Technology

Microarrays

Polymerase Chain Reaction (PCR)

Gene Regulation Technologies (mRNA and RNAi technology)

Next Generation Sequencing (NGS) technologies
Transcriptomics Technologies Market, by Application

Clinical Diagnostics

Drug Discovery and Research

Bioinformatics

Comparative Transcriptome studies
Transcriptomics Technologies Market, by Geography

North America

Europe

Asia-Pacific

Rest of the World (RoW)
TABLE OF CONTENTS
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 List of Abbreviations

4. Browse the full report with Complete TOC
at http://www.transparencymarketresearch.com/transcriptomics-technologiesmarket.html
Chapter 2 Executive Summary
Chapter 3 Market Overview
3.1 Introduction
3.1.1 Market Potential of Transcriptomics Technologies
3.1.2 Future Scenario of Transcriptomics
3.1.3 Market Dynamics
3.2 Market Drivers
3.2.1 Technological Advancements
3.2.2 Rising Preference for Personalized Medicine from both ends (Manufacturers and
Consumers)
3.2.3 Increasing Research and Development Investments
3.2.4 Impact Analysis of Market Drivers
3.3 Market Restraints
3.3.1 Lack Of Efficient Data Analysis Tools
3.3.2 Impact Analysis of Market Restraints
3.4 Market Opportunities
3.4.1 Focus on Development of Bioinformatics Tools and Services
3.5 Porter’s Five Forces Analysis: Global Transcriptomics Technologies Market
3.5.1 Bargaining Power Of Buyers
3.5.2 Bargaining Power Of Suppliers
3.5.3 Threat of Substitutes
3.5.4 Threat of New Entrants
3.5.5 Competitive Rivalry

5. 3.6 Market Attractiveness Analysis: Global Transcritpomics Technologies Market, By
Geography
Chapter 4 Global Transcriptomics Technologies Market, By Technology
4.1 Introduction
4.2 Microarrays
4.2.1 Global Microarrays Market, Size and Forecast, 2011 - 2019 (USD Million)
4.2.2 Polymerase Chain Reaction (PCR)
4.2.2.1 Global PCR Market, Size and Forecast, 2011 - 2019 (USD Million)
4.2.3 Gene Regulation Technologies (RNA Interference Technology)
4.2.3.1 Global Gene Regulation Technologies Market, Size and Forecast, 2011 2019 (USD Million)
4.2.4 Next Generation Sequencing (NGS)
4.2.4.1 Global Next Generation Sequencing Technologies Market, Size and
Forecast, 2011 - 2019 (USD Million)
Chapter 5 Global Transcriptomics Technologies Market, By Application
5.1 Overview
5.2 Clinical Diagnostics
5.2.1 Global Clinical Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)
5.3 Drug Discovery And Research
5.3.1 Global Drug Discovery and Research Market, Size and Forecast, 2011 - 2019
(USD Million)
5.4 Bioinformatics
5.4.1 Global Bioinformatics Market, Size and Forecast, 2011 - 2019 (USD Million)
5.5 Comparative Transcriptome Studies
5.5.1 Global Comparative Transcriptome Studies Market, Size and Forecast, 2011 2019 (USD Million)

6. Related & Recently Published Reports by Transparency Market Research

Atrial Fibrillation
Market: http://www.transparencymarketresearch.com/atrial-fibrillationmarket.html

Freeze Drying Equipment
Market: http://www.transparencymarketresearch.com/freeze-dryingequipment-market.html

Metal Cans Market: http://www.transparencymarketresearch.com/metalcans-market.html
Chapter 6 Global Transcriptomics Technologies Market, By Geography
6.1 Overview
6.1.1 Global Transcriptomics Technologies Market, By Geography, Size and Forecast,
2011 – 2019 (USD Million)
6.1.2 Comparative Analysis: Global Transcriptomics Technologies Market, By
Geography, 2012 & 2019 (Value %)
6.2 North America
6.2.1 North America Transcriptomics Technologies Market, Size and Forecast, 2011 2019 (USD Million)
6.3 Europe
6.3.1 Europe Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019
(USD Million)
6.4 Asia-Pacific
6.4.1 Asia-Pacific Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019
(USD Million)
6.5 Rest of the World (Row)
6.5.1 Row Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD
Million)

7. Chapter 7 Competitive Landscape
7.1 Market Share By Key Players: Global Transcriptomics Technologies Market, 2012 (%)
Chapter 8 Recommendations
8.1 Collaboration with Academic and Research Institutes
8.2 Focus on Imparting Education about Genomic Medicine
Chapter 9 Company Profiles
9.1 Affymetrix, Inc.
9.1.1 Company Overview
9.1.2 Financial Overview
9.1.3 Product Portfolio
9.1.4 Business Strategies
9.1.5 Recent Developments
9.2 Agilent Technologies, Inc.
9.2.1 Company Overview
9.2.2 Financial Overview
9.2.3 Product Portfolio
9.2.4 Business Strategies
9.2.5 Recent Developments
9.3 Bio-Rad Laboratories, Inc.
9.3.1 Business Overview
9.3.2 Financial Overview
9.3.3 Product Portfolio
9.3.4 Business Strategies
9.3.5 Recent Developments

8. 9.4 Danaher Corporation
9.4.1 Business Overview
9.4.2 Financial Overview
9.4.3 Product Portfolio
9.4.4 Business Strategies
9.4.5 Recent Developments
9.5 F. Hoffmann-La Roche Ltd.
9.5.1 Company Overview
9.5.2 Financial Overview
9.5.3 Product Portfolio
9.5.4 Business Strategies
9.5.5 Recent Developments
9.6 Illumina, Inc.
9.6.1 Company Overview
9.6.2 Financial Overview
9.6.3 Product Portfolio
9.6.4 Business Strategies
9.6.5 Recent Developments
9.7 Life Technologies Corporation
9.7.1 Company Overview
9.7.2 Financial Overview
9.7.3 Product Portfolio
9.7.4 Business Strategies
9.7.5 Recent Developments
9.8 LC Sciences, LLC

9. 9.8.1 Company Overview
9.8.2 Financial Overview
9.8.3 Product Portfolio
9.8.4 Business Strategies
9.8.5 Recent Developments
9.9 Qiagen N.V.
9.9.1 Company Overview
9.9.2 Financial Overview
9.9.3 Product Portfolio
9.9.4 Business Strategies
9.9.5 Recent Developments
9.10 Sigma-Aldrich Corporation
9.10.1 Company Overview
9.10.2 Financial Overview
9.10.3 Product Portfolio
9.10.4 Business Strategies
9.10.5 Recent Developments
9.11 Thermo Fisher Scientific
9.11.1 Company Overview
9.11.2 Financial Overview
9.11.3 Product Portfolio
9.11.4 Business Strategies
9.11.5 Recent Developments

10. About Us:
Transparency Market Research is a market intelligence company providing global business
information reports and services. Our exclusive blend of quantitative forecasting and trends
analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants,
who use proprietary data sources and various tools and techniques to gather, and analyze
information. Our business offerings represent the latest and the most reliable information
indispensable for businesses to sustain a competitive edge.
Contact:
Transparency Market Research
90 State Street,
Suite 700, Albany,NY – 12207,
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
Browse the full report with Complete TOC
at http://www.transparencymarketresearch.com/transcriptomics-technologiesmarket.html